Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Microneedles improve delivery of plant-based compounds through the skin, aiding treatments for hair loss, cancer, and wounds.

A nano-formula of quercetin effectively improves heart health in metabolic syndrome.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Baricitinib is effective and safe for treating severe alopecia areata.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

SIRT7 protein is crucial for starting hair growth in mice.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.